FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132044706> ?p ?o ?g. }

• W3132044706 endingPage "07" @default.
• W3132044706 startingPage "SS2" @default.
• W3132044706 abstract "Abstract Background The outbreak of COVID-19 pandemic in China has greatly impacted the radiotherapy (RT) strategy for breast cancer (BC) patients, which might lead to an increased distressing psychological symptom. Thus, we perform a multi-center cross-section survey aiming to investigate the prevalence of fears of cancer recurrence (FCR) and explore predictors for FCR in BC patients referred for RT during pandemic. Methods: 542 BC patients who referred for RT between 24th Jan and 30th April 2020 during pandemic were consecutively enrolled from 14 hospitals around China including Yangtze Delta River Region, Guangdong and Shanxi province. Patients’ sociodemographic, treatment information as well as psychological characteristics were collected using an information sheet, Fear of progression questionnaire-short form (FoP-Q-SF), Hospital Anxiety and Depression Scale (HADS) and EORTC QLQ-C30. The influence of pandemic on RT schedule was divided into four categories: “delay” was defined as &gt;12 weeks from surgery to RT in patients without chemotherapy or &gt;8 weeks from last time of anti-tumor therapy (including chemotherapy and surgery) to RT in patients with chemotherapy; “Special normal” was defined that patients themselves believed to have delayed RT initiation but actually not; “Interruption” was defined as any unplanned gaps in original RT regime and all other would be classified into “normal”. Another type of influence on RT strategy was that patients had to shift planned RT hospital from Grade-A tertiary hospital to local hospitals. Univariable analyses of FCR were performed in a one-way analysis of variance (ANOVA) or student t-test or Pearson correlation analyses and candidate variables with P&lt;0.2 were included Hierarchical multiple regression models to investigate predictors for FCR. Guangdong province was chosen as reference in models. Results 488 patients with complete data were eligible for the present analysis and none of patients and their family members had been diagnosed as COVID-19. The RT strategy was affected in 265 (54.3%) patients, including 143 with delayed RT initiation, 66 with “special normal” schedule, 24 (4.9%) with RT interruptions, 19 shifting to local hospitals for RT, and the remaining 13 being influenced on both RT schedule and planned RT hospitals. Most of patients with affected RT strategy occurred in late January and February, when was peak of COVID-19 pandemic in China. The mean FCR scores was 24.83 (SD=8.554) and 84 patients (17.3%) were classified as dysfunctional level of FCR (sum score ≥34). In univariable analyses, FCR were significantly higher in patients who received RT in Guangdong province and in hospitals with &lt; 100 BC cases per year. In term of during pandemic, a significant difference in FCR was observed in terms of influence on RT schedule (p&lt;0.001). and changes of hospital levels(p=0.009). There were significant correlations between FCR and anxiety/depressive in HADS or all five function scales (physical, role, emotional, cognitive and social) and global QoL in QLQ-C30 (p&lt;0.001). Finally, the model explained 59.7% of observed variances in FCR and showed that influence of RT strategy during pandemic had significantly impacted on FCR (ΔR2=0.01, ΔF=2.966, p=0.019). Hospitals in Shanxi province (β=-0.117, p=0.001), emotional function (β=-0.19, p&lt;0.001), social function (β=-0.111, p=0.006), anxiety (β=0.434, p&lt;0.001) and RT interruption (β=0.071, p=0.035) were independent predictors for FCR. Conclusions RT strategy for BC patients was greatly influenced during pandemic. RT interruption is an independent predictor for high FCR. Our findings emphasize the necessity to ensure the continuum of RT in BC patients, and efforts should be taken to alleviate the FCR through psychological interventions. Citation Format: Jinrong Xie, Weixiang Qi, Lu Cao, Yuting Tan, Jin Huang, Xiaodong Gu, Bingguang Chen, Peipei Shen, Ying Zhang, Qingwen Zhao, Hecheng Huang, Yubin Wang, Haicheng Fang, Zhenjun Jin, Hui Li, Xuehong Zhao, Xiaofang Qian, Feifei Xu, Dan Ou, Shubei Wang, Cheng Xu, Min Li, Zefei Jiang, Yu Wang, Xiaobo Huang, Jiayi Chen. Predictors for fear of cancer recurrence in breast cancer patients referred for radiation therapy during the COVID-19 pandemic: A multi-center cross-section survey [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr SS2-07." @default.
• W3132044706 created "2021-03-01" @default.
• W3132044706 creator A5003816686 @default.
• W3132044706 creator A5004726461 @default.
• W3132044706 creator A5009312738 @default.
• W3132044706 creator A5010390436 @default.
• W3132044706 creator A5013687810 @default.
• W3132044706 creator A5015352649 @default.
• W3132044706 creator A5017476303 @default.
• W3132044706 creator A5019900083 @default.
• W3132044706 creator A5025594364 @default.
• W3132044706 creator A5029030007 @default.
• W3132044706 creator A5035514027 @default.
• W3132044706 creator A5035915384 @default.
• W3132044706 creator A5036477294 @default.
• W3132044706 creator A5038853831 @default.
• W3132044706 creator A5039309782 @default.
• W3132044706 creator A5039619096 @default.
• W3132044706 creator A5043228938 @default.
• W3132044706 creator A5058376130 @default.
• W3132044706 creator A5061126882 @default.
• W3132044706 creator A5066583151 @default.
• W3132044706 creator A5067897285 @default.
• W3132044706 creator A5074131698 @default.
• W3132044706 creator A5076149259 @default.
• W3132044706 creator A5077458638 @default.
• W3132044706 creator A5086782158 @default.
• W3132044706 creator A5091432278 @default.
• W3132044706 date "2021-02-15" @default.
• W3132044706 modified "2023-09-30" @default.
• W3132044706 title "Abstract SS2-07: Predictors for fear of cancer recurrence in breast cancer patients referred for radiation therapy during the COVID-19 pandemic: A multi-center cross-section survey" @default.
• W3132044706 doi "https://doi.org/10.1158/1538-7445.sabcs20-ss2-07" @default.
• W3132044706 hasPublicationYear "2021" @default.
• W3132044706 type Work @default.
• W3132044706 sameAs 3132044706 @default.
• W3132044706 citedByCount "0" @default.
• W3132044706 crossrefType "journal-article" @default.
• W3132044706 hasAuthorship W3132044706A5003816686 @default.
• W3132044706 hasAuthorship W3132044706A5004726461 @default.
• W3132044706 hasAuthorship W3132044706A5009312738 @default.
• W3132044706 hasAuthorship W3132044706A5010390436 @default.
• W3132044706 hasAuthorship W3132044706A5013687810 @default.
• W3132044706 hasAuthorship W3132044706A5015352649 @default.
• W3132044706 hasAuthorship W3132044706A5017476303 @default.
• W3132044706 hasAuthorship W3132044706A5019900083 @default.
• W3132044706 hasAuthorship W3132044706A5025594364 @default.
• W3132044706 hasAuthorship W3132044706A5029030007 @default.
• W3132044706 hasAuthorship W3132044706A5035514027 @default.
• W3132044706 hasAuthorship W3132044706A5035915384 @default.
• W3132044706 hasAuthorship W3132044706A5036477294 @default.
• W3132044706 hasAuthorship W3132044706A5038853831 @default.
• W3132044706 hasAuthorship W3132044706A5039309782 @default.
• W3132044706 hasAuthorship W3132044706A5039619096 @default.
• W3132044706 hasAuthorship W3132044706A5043228938 @default.
• W3132044706 hasAuthorship W3132044706A5058376130 @default.
• W3132044706 hasAuthorship W3132044706A5061126882 @default.
• W3132044706 hasAuthorship W3132044706A5066583151 @default.
• W3132044706 hasAuthorship W3132044706A5067897285 @default.
• W3132044706 hasAuthorship W3132044706A5074131698 @default.
• W3132044706 hasAuthorship W3132044706A5076149259 @default.
• W3132044706 hasAuthorship W3132044706A5077458638 @default.
• W3132044706 hasAuthorship W3132044706A5086782158 @default.
• W3132044706 hasAuthorship W3132044706A5091432278 @default.
• W3132044706 hasConcept C118552586 @default.
• W3132044706 hasConcept C121608353 @default.
• W3132044706 hasConcept C126322002 @default.
• W3132044706 hasConcept C139719470 @default.
• W3132044706 hasConcept C162324750 @default.
• W3132044706 hasConcept C2776694085 @default.
• W3132044706 hasConcept C2776867660 @default.
• W3132044706 hasConcept C2779134260 @default.
• W3132044706 hasConcept C3008058167 @default.
• W3132044706 hasConcept C509974204 @default.
• W3132044706 hasConcept C524204448 @default.
• W3132044706 hasConcept C530470458 @default.
• W3132044706 hasConcept C558461103 @default.
• W3132044706 hasConcept C71924100 @default.
• W3132044706 hasConcept C89623803 @default.
• W3132044706 hasConceptScore W3132044706C118552586 @default.
• W3132044706 hasConceptScore W3132044706C121608353 @default.
• W3132044706 hasConceptScore W3132044706C126322002 @default.
• W3132044706 hasConceptScore W3132044706C139719470 @default.
• W3132044706 hasConceptScore W3132044706C162324750 @default.
• W3132044706 hasConceptScore W3132044706C2776694085 @default.
• W3132044706 hasConceptScore W3132044706C2776867660 @default.
• W3132044706 hasConceptScore W3132044706C2779134260 @default.
• W3132044706 hasConceptScore W3132044706C3008058167 @default.
• W3132044706 hasConceptScore W3132044706C509974204 @default.
• W3132044706 hasConceptScore W3132044706C524204448 @default.
• W3132044706 hasConceptScore W3132044706C530470458 @default.
• W3132044706 hasConceptScore W3132044706C558461103 @default.
• W3132044706 hasConceptScore W3132044706C71924100 @default.
• W3132044706 hasConceptScore W3132044706C89623803 @default.
• W3132044706 hasIssue "4_Supplement" @default.
• W3132044706 hasLocation W31320447061 @default.
• W3132044706 hasOpenAccess W3132044706 @default.
• W3132044706 hasPrimaryLocation W31320447061 @default.
• W3132044706 hasRelatedWork W2107151264 @default.

• next